Sources Sought Notice -ZOLPIDEM 12.5MG AND 6.25MG
ID: 36C77025Q0185Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/b1fab503554b444e9b0d2bd7302185c8/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential vendors for the supply of Zolpidem Tartrate tablets in 12.5 mg and 6.25 mg dosages, each in 100-count packages, intended for distribution through the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This Request for Information (RFI) aims to gather insights on qualified sources capable of fulfilling these pharmaceutical requirements, emphasizing the need for vendors to confirm their licensing, registration with SAM.gov, and, if applicable, their status as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. The procurement process is in its preliminary stages, and responses will assist the VA in assessing marketplace capabilities without committing to a contract or incurring costs. Interested parties should submit their responses via email to Larry Zaritz at larry.zaritz@va.gov by 10:00 AM CST on February 7, 2025.

    Point(s) of Contact
    Larry Zaritz
    (913) 684-0156
    larry.zaritz@va.gov
    Files
    Title
    Posted
    Sources Siught Notice.docx
    The Department of Veterans Affairs (VA) has issued a Sources Sought Notice for pharmaceuticals, specifically Zolpidem Tartrate tablets (12.5 mg and 6.25 mg, 100 count each), intended for distribution through the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This document serves as a Request for Information (RFI) to identify potential vendors capable of fulfilling these requirements. Vendors must confirm their licensing to distribute pharmaceuticals, registration with SAM.gov, and, if applicable, registration as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. Responses will aid the VA in understanding the marketplace capabilities without committing to a contract or incurring costs. Interested parties are instructed to submit their responses to the provided contact email before the deadline of February 7, 2025, at 10:00 AM CST. This notice emphasizes the government's intent to gather information rather than soliciting formal bids or proposals at this stage.
    Lifecycle
    Title
    Type
    Sources Sought Notice -ZOLPIDEM 12.5MG AND 6.25MG
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0180 762-25-2-040-1379 -Tucson CMOP LURASIDONE
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to supply Lurasidone HCL 20mg tablets in 30-count bottles for the Tucson CMOP facility under solicitation number 36C77025Q0180. The procurement aims to fulfill a standard requirement for essential pharmaceuticals, emphasizing compliance with the Buy American statute and the Drug Supply Chain Security Act (DSCSA). This opportunity is critical for ensuring that veterans receive necessary medications in a timely manner, with a delivery timeframe of 10 days after receipt of order. Interested vendors must submit their quotes, including a signed SF1449 cover page, price schedule in Excel format, and a completed Buy American Certificate, to Michael W McAlhaney at Michael.McAlhaney@va.gov by March 19, 2025, with an estimated award date of March 24, 2025.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    Leavenworth CMOP 11 PHARMACEUTICALS
    Buyer not available
    The Department of Veterans Affairs is seeking interest from potential contractors for the supply of domestically manufactured pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) program, as outlined in the Sources Sought Notice 36C77025Q0183. The VA is specifically looking for responses from both small and large pharmaceutical manufacturers and distributors capable of providing a specified list of medications, including Galantamine Hydrobromide and Hydrocortisone Ointment, among others. This initiative is crucial for ensuring a reliable pharmaceutical supply chain for veterans’ healthcare, aligning with Federal Acquisition Regulations to foster early dialogue about acquisitions. Interested parties must submit their responses to Sarah Fry at sarah.fry2@va.gov by March 18, 2025, as this is an information-gathering activity without any contractual obligations.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0179 762-25-2-040-1352 -Tucson CMOP HYDROCORTISONE
    Buyer not available
    The Department of Veterans Affairs is seeking bids for the procurement of Hydrocortisone Acetate pharmaceuticals to be delivered to its Tucson CMOP facility under solicitation number 36C77025Q0179. The requirement includes specific quantities of two formulations of Hydrocortisone Acetate, each in different package sizes, and the opportunity is set aside for small businesses. This procurement is crucial for enhancing the supply chain capabilities to meet the medical needs of veterans, with a response deadline of March 18, 2025, and an estimated award date of March 21, 2025. Interested vendors must submit their bids via email to Contract Specialist Michael W. McAlhaney, including a signed SF1449 cover page, an Excel-based price schedule, a valid state wholesale distributor license, and a completed Buy American certificate.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Fludrocortisone Acetate 0.1MG Tablets, packaged in bottles of 100 tablets, to ensure a reliable supply for various federal entities, including the Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to award a single contract that covers an initial term of one year, with the option for four additional one-year periods, thereby securing an uninterrupted source of this essential medication. The estimated annual requirement for the tablets is 31,127 bottles, and interested suppliers must provide a unique NDC or UPC number along with the product name as it appears on the label. The solicitation is expected to be published on or around March 28, 2025, with proposals due by April 11, 2025; inquiries can be directed to Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    SUMATRIPTAN 6MG/0.5ML
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to supply Sumatriptan 6mg/0.5ml injection syringes, specifically packaged as two syringes per package, for use in treating certain types of headaches. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA), necessitating that suppliers provide documentation such as a state wholesale distributor license along with their quotes. This solicitation is critical for ensuring the availability of essential pharmaceutical supplies to veterans, with the RFQ (36C77025Q0171) set to be issued on March 13, 2025, and closing on March 19, 2025, at 5:00 PM CST. Interested vendors should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details and to ensure compliance with all regulatory requirements.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    Pharmaceuticals for Leavenworth CMOP
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply nine pharmaceuticals for delivery to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) in Kansas. This procurement, categorized under Solicitation Number 36C77025Q0173, includes medications such as Nitroglycerin ointment, Ondansetron tablets, and Pioglitazone tablets, with specific quantities and packaging requirements outlined in the solicitation. The pharmaceuticals are essential for providing necessary medical treatments to veterans, reflecting the VA's commitment to maintaining a reliable supply chain for critical medications. Interested vendors must submit their quotations via email by March 25, 2025, and ensure compliance with the Drug Supply Chain Security Act, with the estimated issue date for the solicitation being March 14, 2025. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.